Uzm. Dr. Mehmet Sezgin Pepeler
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Graft vs Host Disease 4 publicationsSource: OpenAlex / PubMed MeSHView publications
- Leukemia, Myeloid, Chronic-Phase 3 publications
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 publications
- Myeloproliferative Disorders 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologysaglik.gov.trFrom source
- InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
- Area of workGraft vs Host DiseaseExtracted from 4 publications · Model version —From source
- Publications53 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0002-2762-8573ORCIDFrom source
- Last synchronised7 November 2026 00:02https://ankarasehir.saglik.gov.tr/TR-331019/hematoloji-klinigi-doktorlarimiz.html#mehmet-sezgin-pepelersaglik.gov.tr
Scientific work
Publications on Graft vs Host Disease
-
Real-world effectiveness and safety of ruxolitinib in myelofibrosis: a multicenter cohort study (CHART-MF)
Blood Global Hematology, 2026
DOI 10.1016/j.bglo.2026.100162 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Bidirectional Temporal Association Between Cytomegalovirus Reactivation and Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Real-World Cohort Study
Viruses, 2026
DOI 10.3390/v18080874 PMID 42655692 Open-access full textSource: ORCID
-
Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms
International Journal of Endocrinology, 2026
DOI 10.1155/ije/6041016 PMID 42147090 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors
Journal of Clinical Apheresis, 2026
DOI 10.1002/jca.70089 PMID 41500932 Open-access full textSource: ORCID
-
Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia
Indian Journal of Hematology and Blood Transfusion, 2026
DOI 10.1007/s12288-025-02095-8 PMID 41522562 Open-access full textSource: ORCID
-
Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)
Annals of Hematology, 2026
DOI 10.1007/s00277-026-06871-y PMID 41718772 Open-access full textSource: OpenAlex
-
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review
Leukemia Research, 2026
DOI 10.1016/j.leukres.2026.108239 PMID 42090741 Source: OpenAlex
-
The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation
Transfusion and Apheresis Science, 2025
DOI 10.1016/j.transci.2025.104187 PMID 40543289 Source: OpenAlex
-
MİYELOFİBROZİSTE RUKSOLİTİNİBİN GERÇEK YAŞAM ETKİLİLİĞİ VE GÜVENLİLİĞİ: ÇOK MERKEZLİ KOHORT ÇALIŞMASI (CHART-MF)
Kocaeli Üniversitesi - AVESİS, 2025
Source: OpenAlex
-
The Reality of Hematopoietic Stem Cell Transplantation in a Pandemic: How Has COVID-19 Impacted Graft-versus-Host Disease and Mortality?
Flora the Journal of Infectious Diseases and Clinical Microbiology, 2025
DOI 10.5578/flora.2025031387 Open-access full textSource: OpenAlex